Gene · 6392
Papers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic Rewiring and the Characterization of Oncometabolites. | Cancers (Basel) | 2021 | 34200553 | PubTator, text mining | PubMed |
| Mitochondrial Tumor Suppressors-The Energetic Enemies of Tumor Progression. | Cancer Res | 2021 | 34183354 | PubTator, text mining | PubMed |
Succinate Dehydrogenase Complex Iron Sulfur Subunit B (SDHB) Immunohistochemistry in Pheochromocytoma, Head and Neck Paraganglioma, Thoraco-Abdomino-Pelvic Paragangliomas: Is It a Good Idea to Use in Routine Work? | Asian Pac J Cancer Prev | 2021 | 34181326 | PubTator, text mining | PubMed |
| WRN Germline Mutation Is the Likely Inherited Etiology of Various Cancer Types in One Iranian Family. | Front Oncol | 2021 | 34164337 | PubTator, text mining | PubMed |
| Composition and stage dynamics of mitochondrial complexes in Plasmodium falciparum. | Nat Commun | 2021 | 34155201 | PubTator, text mining | PubMed |
| New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. | Arch Toxicol | 2021 | 34151400 | PubTator, text mining | PubMed |
| Ovarian cancer modulates the immunosuppressive function of CD11b+Gr1+ myeloid cells via glutamine metabolism. | Mol Metab | 2021 | 34144215 | PubTator, text mining | PubMed |
Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials. | ESMO Open | 2021 | 34139487 | PubTator, text mining | PubMed |
| COSMIC Cancer Gene Census 3D database: understanding the impacts of mutations on cancer targets. | Brief Bioinform | 2021 | 34137435 | PubTator, text mining | PubMed |
| A patient with paraganglioma undergoing laparoscopic resection: A case report. | Clin Case Rep | 2021 | 34136230 | PubTator, text mining | PubMed |
| Familial Acromegaly and Bilateral Asynchronous Pheochromocytomas in a Female Patient With a MAX Mutation: A Case Report. | Front Endocrinol (Lausanne) | 2021 | 34135865 | PubTator, text mining | PubMed |
| Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden. | BMC Cancer | 2021 | 34130653 | PubTator, text mining | PubMed |
| Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate. | Cancer Res | 2021 | 34127497 | PubTator, text mining | PubMed |
| Complex II subunit SDHD is critical for cell growth and metabolism, which can be partially restored with a synthetic ubiquinone analog. | BMC Mol Cell Biol | 2021 | 34118887 | PubTator, text mining | PubMed |
| High throughput proteomic and metabolic profiling identified target correction of metabolic abnormalities as a novel therapeutic approach in head and neck paraganglioma. | Transl Oncol | 2021 | 34118692 | PubTator, text mining | PubMed |
| Characterization of the small RNA transcriptomes of cell protrusions and cell bodies of highly metastatic hepatocellular carcinoma cells via RNA sequencing. | Oncol Lett | 2021 | 34113396 | PubTator, text mining | PubMed |
| Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma. | Endocrinol Diabetes Metab Case Rep | 2021 | 34110302 | PubTator, text mining | PubMed |
| Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD. | Cancer Genet | 2021 | 34107390 | PubTator, text mining | PubMed |
| Low chorionic villous succinate accumulation associates with recurrent spontaneous abortion risk. | Nat Commun | 2021 | 34103526 | PubTator, text mining | PubMed |
| Malignant prediction in paragangliomas: analysis for clinical risk factors. | Langenbecks Arch Surg | 2021 | 34101001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6392/papers?page=42